non-immunosuppressive cyclophilin inhibitor

oral activity in humanized HCV model

from semisynthetic deriv. of FR901459

Bioorg. Med. Chem. Lett., Jun. 2, 2020

Astellas Pharma, Ibaraki, JP

ASP5286 is an analog of the natural product cyclosporin A that maintains the anti-HCV activity of cyclosporin A by binding to cyclophilin, but was optimized to be less immunosuppresive than…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks